SCHEMBL628971

SCHEMBL628971

C=C(I)N1CCCC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL810605 0.91 LMNA (0.44)
SCHEMBL5839331 0.79
SCHEMBL8658303 0.77
SCHEMBL2877519 0.77
SCHEMBL195052 0.77
SCHEMBL8579741 0.77
SCHEMBL7063095 0.77 LMNA (0.52)
SCHEMBL3149604 0.76
SCHEMBL2705725 0.74
SCHEMBL2537024 0.74 LMNA (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1131050-B1 GALENIC FORMULATIONS FAST DISINTEGRATING IN THE MOUTH AND METHOD FOR PREPARING SAME CLL PHARMA (FR) 2004-05-26 EP claimed
CN-1116904-C Wound covering material containing silk fibroin and silk sericin as main components and process for producing the same JP NAT INST OF AGRICULTURAL AN (JP) 2003-08-06 CN claimed
US-12582956-B2 Articles of manufacture with polyurea capsules cross-linked with chitosan ENCAPSYS, LLC 2026-03-24 US disclosed
US-20250205668-A1 Articles of Manufacture with Polyurea Capsules Cross-linked with Chitosan ENCAPSYS, LLC (US) 2025-06-26 US disclosed
US-20250114457-A1 PHARMACEUTICAL COMPOSITIONS OF FUMARIC ACID ESTERS HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT 2025-04-10 US disclosed
EP-4471882-A1 CATHODE ACTIVE MATERIAL FOR LITHIUM SECONDARY BATTERY, METHOD OF PREPARING THE SAME AND LITHIUM SECONDARY BATTERY INCLUDING THE SAME SK On Co., Ltd. (KR) 2024-12-04 EP disclosed
US-20220153901-A1 Poly Acrylate and Poly(Beta-Amino Ester) Capsules with Enhanced Degradability Encapsys,LLC (US) 2022-05-19 US disclosed
EP-2399978-B2 Stable non-aqueous liquid compositions comprising a cationic polymer in particulate form PROCTER & GAMBLE (US) 2020-11-25 EP disclosed
EP-3728215-A1 PREPARATION OF RACEMIC NICOTINE BY REACTION OF ETHYL NICOTINATE WITH N-VINYLPYRROLIDONE IN THE PRESENCE OF AN ALCOHOLATE BASE AND SUBSEQUENT PROCESS STEPS Siegfried AG (CH) 2020-10-28 EP disclosed
EP-3710437-A1 ENANTIOMERIC SEPARATION OF RACEMIC NICOTINE BY ADDITION OF AN O,O'-DISUBSTITUTED TARTARIC ACID ENANTIOMER Siegfried AG (CH) 2020-09-23 EP disclosed
EP-3698793-A1 BESIFLOXACIN FOR THE TREATMENT OF RESISTANT ACNE Vyome Therapeutics Limited (IN) 2020-08-26 EP disclosed
US-20050259303-A1 Long-term high temperature and humidity stable holographic optical data storage media compositions with exceptional high dynamic range ACADIA WOODS PARTNERS, LLC 2005-11-24 US disclosed
WO-2004103335-A1 COSMETIC COMPOSITIONS COMPRISING A POLYMER AND A COLORANT THE PROCTER & GAMBLE COMPANY (US) 2004-12-02 WO disclosed
US-20040231070-A1 Cosmetic compositions comprising a polymer and a colorant THE PROCTER & GAMBLE COMPANY 2004-11-25 US disclosed
US-20040122002-A1 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof MERCKLE GMBH (DE) 2004-06-24 US disclosed
US-6462030-B1 MICROBIOCIDES TO MYCOPLASMA HOMINIS, MYCOPLASMA CAPRICOLUM, MOBILUNCUS CURTISII AND PREVOTELLA CORPORIS NEW YORK BLOOD CENTER, INC. 2002-10-08 US disclosed
US-6407042-B1 ANALYZING USING MICROSCOPE MONSANTO TECHNOLOGY LLC 2002-06-18 US disclosed
EP-0889713-B1 CONDITIONING SHAMPOO COMPOSITIONS CONTAINING POLYALPHAOLEFIN CONDITIONER PROCTER & GAMBLE (US) 2001-05-16 EP disclosed
EP-0143476-A1 Dosing unit comprising a detergent and/or bleaching agent AKZO N.V. (NL) 1985-06-05 EP disclosed
EP-0077064-A1 Photographic element comprising a layer containing a cross-linked polymer EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1983-04-20 EP disclosed